Amgen Inc’s Next Blockbuster Drug Delivers

On Thursday's edition of Market Checkup, The Motley Fool's health-care focused show for investors, Fool health-care analyst David Williamson sheds some light on what's driving the biggest movers in the health-care space today.

Amgen (NASDAQ: AMGN  ) has just released phase 3 data for its PCSK9 drug, AMG 145, and the results are impressive. Drugs that aim to block the PCSK9 enzyme have the potential to lower cholesterol levels in patients, and AMG 145 has met both of its phase 3 endpoints while remaining relatively well-tolerated by the trial patients. In a phase 2 trial, AMG 145, also called evolocumab, led to a 51% reduction in LDL levels, which rose to a 63% reduction when combined with a statin. David emphasizes just how much more effective this is than the currently available treatments on the market, and discusses why this drug could be a multi-billion dollar blockbuster. He also discusses some of Amgen's competitors, and tells investors who else could be affected as this drug potentially makes its way to market.

More great biotech investing ideas?
The best way to play the biotech space is to find companies that shun the status quo and, instead, discover revolutionary, groundbreaking technologies. In the Motley Fool's brand-new FREE report, "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2807506, ~/Articles/ArticleHandler.aspx, 10/24/2014 11:25:00 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement